Report Code: CMI51057

Category: Healthcare

Report Snapshot

CAGR: 9.8%
14,125.1M
2023
15,509.4M
2024
35,976.2M
2033

Source: CMI

Study Period: 2024-2033
Fastest Growing Market: Asia-Pacific
Largest Market: Europe

Major Players

  • Allergan plc (now part of AbbVie)
  • Galderma S.A.
  • Merz Pharma GmbH & Co. KGaA
  • Sinclair Pharma plc
  • Suneva Medical Inc.
  • Teoxane Laboratories
  • Others

Exclusive, in-depth market intelligence can help you increase your Revenue.

Download Sample Pdf

Reports Description

As per the current market research conducted by the CMI Team, the global Aesthetics Injectables Market is expected to record a CAGR of 9.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 15,509.4 Million. By 2033, the valuation is anticipated to reach USD 35,976.2 Million.

The aesthetics injectables market encompasses a diverse range of non-invasive cosmetic treatments aimed at enhancing facial aesthetics and addressing signs of aging. These treatments include botulinum toxin injections, dermal fillers, and collagen stimulators, among others.

With a growing aging population, increasing beauty consciousness, and advancements in product formulations and delivery techniques, the aesthetics injectables market continues to expand globally. Key drivers include the demand for minimally invasive procedures, rising disposable incomes, and the influence of social media and celebrity endorsements, contributing to sustained growth in the market.

Aesthetics Injectables Market – Significant Growth Factors

The Aesthetics Injectables Market presents significant growth opportunities due to several factors:

  • Aging Population: The growing aging population worldwide drives demand for aesthetics injectables as individuals seek non-invasive solutions to address signs of aging such as wrinkles, fine lines, and volume loss, fueling the market growth.
  • Increasing Beauty Consciousness: Rising beauty consciousness, influenced by social media and the desire for youthful appearances, propels individuals to opt for aesthetic procedures, stimulating market expansion.
  • Technological Advancements: Continuous innovations in injectable formulations and delivery techniques improve safety, efficacy, and patient satisfaction, attracting more consumers and driving market growth.
  • Rising Disposable Income: Increasing disposable incomes, especially in emerging economies, enable more individuals to afford aesthetics injectables, leading to higher consumer spending on cosmetic procedures and driving market expansion.
  • Expansion of Product Portfolio: Opportunities exist for companies to expand their product portfolios to include novel injectable formulations targeting specific aesthetic concerns or offering enhanced longevity and natural-looking results.
  • Geographical Expansion: With increasing demand for aesthetics injectables globally, opportunities arise for companies to expand into untapped markets or strengthen their presence in emerging regions through strategic partnerships, acquisitions, and distribution agreements.

Aesthetics Injectables Market – Mergers and Acquisitions

The Aesthetics Injectables Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Aesthetics Injectables Market include:

  • In 2023, Galderma’s Restylane Eyelight, a hyaluronic acid filler, obtained FDA approval, enhancing the company’s product range and revenue prospects. The approval signifies an opportunity for Galderma to broaden its market presence and capitalize on the demand for aesthetic injectables in the United States.
  • In 2022, Merz Aesthetics introduced Radiesse (+), the first aesthetic injectable designed to address moderate to severe loss of jawline contour. This innovative product fills a crucial gap in the market, offering a specialized solution for patients seeking facial rejuvenation and enhancement.

These mergers and acquisitions helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Aesthetics Injectables Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.

COMPARATIVE ANALYSIS OF THE RELATED MARKET

Aesthetics Injectables Market CAR T-Cell Therapy Market Medical Aesthetics Market
CAGR 9.8% (Approx) CAGR 18.1% (Approx) CAGR 8.4% (Approx)
USD 35,976.2 Million by 2033 USD 14,859.1 Million by 2033 USD 36,168.8 Million by 2033

Aesthetics Injectables Market – Significant Threats

The Aesthetics Injectables Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:

  • Regulatory Challenges: Stringent regulations governing aesthetics injectables pose a significant threat to market players, as compliance costs increase and regulatory approvals become more stringent, potentially hindering product innovation and market entry.
  • Safety Concerns: Adverse events and complications associated with aesthetics injectables, such as infections, allergic reactions, and tissue necrosis, pose a threat to patient safety and can lead to legal liabilities, damaged reputations, and decreased consumer trust in the industry.
  • Competition from Alternative Treatments: The rise of alternative cosmetic procedures, such as laser therapy, microdermabrasion, and non-invasive facial rejuvenation techniques, presents a threat to the aesthetics injectables market by diverting consumer demand away from injectable treatments.
  • Counterfeit Products: The proliferation of counterfeit aesthetics injectables in the market poses a significant threat to patient safety and market integrity, as counterfeit products may contain harmful substances, lack efficacy, and compromise treatment outcomes, leading to reputational damage and legal ramifications for legitimate manufacturers.
  • Economic Downturns: Economic downturns, such as recessions or financial crises, can impact consumer spending on elective cosmetic procedures, leading to a decline in demand for aesthetics injectables and reduced revenue for market players, particularly those reliant on discretionary spending from cash-strapped consumers.

Global Aesthetics Injectables Market 2024–2033 (By Gender)

www.custommarketinsight.com

Category-Wise Insights:

By Product Type

  • Botulinum Toxin: Botulinum toxin, commonly known as Botox, is a neurotoxic protein used in aesthetic medicine to temporarily reduce facial wrinkles by paralyzing underlying muscles. Trends in the aesthetics injectables market for botulinum toxin include a growing demand for preventive treatments among younger demographics, advancements in injection techniques for natural-looking results, and expanding applications beyond wrinkle reduction to include facial contouring and medical conditions like migraines.
  • Dermal Fillers: Dermal fillers are injectable gels made from hyaluronic acid or other biocompatible materials used to restore facial volume, smooth wrinkles, and enhance facial contours. Trends in the aesthetics injectables market for dermal fillers include a shift towards natural-looking results with subtle enhancements, the emergence of longer-lasting formulations, and increased demand for non-surgical nose reshaping and lip augmentation procedures.
  • Collagen Stimulators: Collagen stimulators are injectable substances that stimulate the body’s natural collagen production to improve skin elasticity, firmness, and volume over time. Trends in the aesthetics injectables market for collagen stimulators include a focus on long-term results with gradual improvement, combination treatments with other injectables for synergistic effects, and advancements in formulations to minimize downtime and optimize patient comfort.
  • Others: The “others” category in the aesthetics injectables market encompasses a variety of injectable treatments beyond botulinum toxin, dermal fillers, and collagen stimulators. This may include injectable vitamins and antioxidants for skin rejuvenation, mesotherapy cocktails for targeted fat reduction, and platelet-rich plasma (PRP) therapy for skin regeneration and hair restoration. Trends in this segment include personalized treatment plans, combination therapies, and the integration of regenerative medicine techniques for holistic rejuvenation.

By Application

  • Facial Line Correction: Aesthetics injectables for facial line correction target fine lines and wrinkles, smoothing the skin’s surface and restoring a youthful appearance. Trends include the use of botulinum toxin for dynamic wrinkles and dermal fillers for static lines, with a growing preference for natural-looking results and individualized treatment plans tailored to patient facial anatomy.
  • Lip Augmentation: Aesthetic injectables for lip augmentation enhance lip volume, shape, and definition. Trends include the use of hyaluronic acid fillers for natural-looking results, personalized treatment approaches to achieve desired lip proportions, and the popularity of lip contouring techniques for subtle enhancements.
  • Facial Volume Restoration: Injectables for facial volume restoration address age-related volume loss, restoring youthful facial contours and fullness. Trends include the use of hyaluronic acid fillers to replenish lost volume in areas such as the cheeks, temples, and under-eye hollows, with a focus on achieving natural-looking results and personalized treatment plans tailored to the patient facial anatomy.
  • Wrinkle Reduction: Aesthetic injectables for wrinkle reduction target fine lines and wrinkles, smoothing the skin’s surface and minimizing visible signs of aging. Trends include the use of botulinum toxin for dynamic wrinkles and dermal fillers for static lines, with a growing emphasis on combination treatments and preventive aesthetics to address early signs of aging.
  • Others: This category encompasses aesthetic injectables used for various applications beyond facial line correction, lip augmentation, facial volume restoration, and wrinkle reduction. Trends may include injectables for chin augmentation, jawline contouring, non-surgical rhinoplasty, and hand rejuvenation, reflecting evolving patient preferences and aesthetic trends.

Global Aesthetics Injectables Market 2024–2033 (By Product Type)

www.custommarketinsight.com

By Gender

  • Male: In the aesthetics injectables market, the male segment refers to cosmetic treatments sought by men to enhance facial aesthetics and address signs of aging. Trends indicate a rising acceptance of aesthetics injectables among men, driven by the desire to maintain a youthful appearance and compete in the workforce. Popular treatments for men include botulinum toxin injections for wrinkle reduction and dermal fillers for facial volume restoration, catering to masculine beauty ideals.
  • Female: The female segment of the aesthetics injectables market comprises cosmetic treatments sought by women to rejuvenate their appearance and combat aging signs. Trends indicate a growing demand for injectable treatments among women, driven by the desire for youthful and radiant skin. Common procedures include botulinum toxin injections to smooth wrinkles and dermal fillers to enhance facial contours, reflecting feminine beauty ideals and the pursuit of ageless beauty.

By End User

  • Hospitals: Hospitals offer aesthetics injectables as part of their comprehensive medical services, catering to patients seeking cosmetic enhancements in a clinical setting. Trends include the integration of aesthetics departments within hospitals, offering a one-stop solution for patients’ cosmetic needs.
  • Dermatology Clinics: Dermatology clinics specialize in skin care and cosmetic procedures, providing aesthetics injectables to address various dermatological concerns. Trends include personalized treatment plans and a focus on minimally invasive procedures for natural-looking results.
  • Cosmetic Centers: Cosmetic centers focus exclusively on aesthetic treatments, offering a wide range of injectable options for facial rejuvenation and enhancement. Trends include advanced techniques like combination therapies and the use of cutting-edge technologies to achieve optimal outcomes.
  • Ambulatory Surgical Centers: Ambulatory surgical centers provide outpatient surgical procedures, including aesthetics injectables, in a convenient and efficient setting. Trends include the adoption of minimally invasive techniques and the incorporation of holistic wellness services to enhance patient satisfaction.
  • Others: This category include medi-spas, wellness clinics, and specialized aesthetic practices offering injectable treatments. Trends may vary widely based on the specific services and target demographics of these establishments.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 15,509.4 Million
Projected Market Size in 2033 USD 35,976.2 Million
Market Size in 2023 USD 14,125.1 Million
CAGR Growth Rate 9.8% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Product Type, Application, Gender, End-User and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Aesthetics Injectables Market – Regional Analysis

The Aesthetics Injectables Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:

  • North America: In North America, the aesthetics injectables market trends include a high demand for advanced injectable treatments such as neurotoxins and dermal fillers, driven by a strong emphasis on anti-aging and beauty enhancement. Additionally, there is a growing preference for personalized treatment plans and combination therapies tailored to individual patient needs, reflecting a consumer base willing to invest in premium cosmetic procedures.
  • Europe: In Europe, aesthetics injectables market trends encompass a focus on natural-looking results and subtle enhancements, with patients seeking injectable treatments to achieve a refreshed appearance without drastic changes. There’s also a rising demand for innovative injectable formulations and techniques that prioritize safety, efficacy, and patient comfort, reflecting a sophisticated market seeking the latest advancements in cosmetic procedures.
  • Asia-Pacific: In the Asia-Pacific region, aesthetics injectables market trends revolve around the pursuit of Western beauty ideals, with a growing demand for procedures to achieve features such as high cheekbones, defined jawlines, and smooth skin texture. Popular treatments include nose reshaping with fillers and jawline contouring with neurotoxins, driven by a desire for facial harmony and youthfulness influenced by celebrity culture and social media trends.
  • LAMEA (Latin America, Middle East, and Africa): In the LAMEA region, aesthetics injectables market trends are characterized by a focus on holistic beauty and wellness, with patients seeking injectable treatments to enhance facial symmetry, skin luminosity, and overall facial balance. There’s also a growing interest in combination therapies that combine injectables with other aesthetic procedures such as laser treatments and skincare regimens, reflecting a comprehensive approach to beauty and self-care.

Global Aesthetics Injectables Market 2024–2033 (By Million)

www.custommarketinsight.com

Competitive Landscape – Aesthetics Injectables Market

The Aesthetics Injectables Market is highly competitive, with a large number of manufacturers and retailers operating globally. Some of the key players in the market include:

  • Allergan plc (now part of AbbVie)
  • Galderma S.A.
  • Merz Pharma GmbH & Co. KGaA
  • Sinclair Pharma plc
  • Suneva Medical Inc.
  • Teoxane Laboratories
  • Anika Therapeutics Inc.
  • Prollenium Medical Technologies Inc.
  • Luminera Derm Ltd.
  • Revance Therapeutics Inc.
  • Ipsen Pharma
  • Laboratoires Vivacy SAS
  • SciVision Biotech Inc.
  • Merz Aesthetics Inc.
  • AQTIS Medical BV
  • Others

These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.

New players entering the aesthetics injectables market are embracing innovation to differentiate themselves and gain traction. Companies like Revance Therapeutics and SciVision Biotech are leveraging novel formulations and delivery methods to offer enhanced patient experiences and outcomes.

Meanwhile, key players dominating the market include Allergan (now part of AbbVie), Galderma, and Merz Pharma. These market leaders maintain their dominance through extensive product portfolios, established brand reputations, and strategic partnerships with healthcare professionals, ensuring widespread market penetration and sustained growth in the competitive aesthetics injectables landscape.

The Aesthetics Injectables Market is segmented as follows:

By Product Type

  • Botulinum Toxin
  • Dermal Fillers
  • Collagen Stimulators
  • Others

By Application

  • Facial Line Correction
  • Lip Augmentation
  • Facial Volume Restoration
  • Wrinkle Reduction
  • Others

By Gender

  • Male
  • Female

By End-User

  • Hospitals
  • Dermatology Clinics
  • Cosmetic Centers
  • Ambulatory Surgical Centers
  • Others

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Aesthetics Injectables Market, (2024 – 2033) (USD Million)
    • 2.2 Global Aesthetics Injectables Market: snapshot
  • Chapter 3. Global Aesthetics Injectables Market – Industry Analysis
    • 3.1 Aesthetics Injectables Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Aging Population
      • 3.2.2 Increasing Beauty Consciousness
      • 3.2.3 Technological Advancements
      • 3.2.4 Rising Disposable Income
      • 3.2.5 Expansion of Product Portfolio
      • 3.2.6 Geographical Expansion.
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market Attractiveness Analysis By Product Type
      • 3.7.2 Market Attractiveness Analysis By Application
      • 3.7.3 Market Attractiveness Analysis By Gender
      • 3.7.4 Market Attractiveness Analysis By End-User
  • Chapter 4. Global Aesthetics Injectables Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Aesthetics Injectables Market: company market share, 2023
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaboration, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Aesthetics Injectables Market – Product Type Analysis
    • 5.1 Global Aesthetics Injectables Market Overview: By Product Type
      • 5.1.1 Global Aesthetics Injectables Market Share, By Product Type, 2023 and 2033
    • 5.2 Botulinum Toxin
      • 5.2.1 Global Aesthetics Injectables Market by Botulinum Toxin, 2024 – 2033 (USD Million)
    • 5.3 Dermal Fillers
      • 5.3.1 Global Aesthetics Injectables Market by Dermal Fillers, 2024 – 2033 (USD Million)
    • 5.4 Collagen Stimulators
      • 5.4.1 Global Aesthetics Injectables Market by Collagen Stimulators, 2024 – 2033 (USD Million)
    • 5.5 Others
      • 5.5.1 Global Aesthetics Injectables Market by Others, 2024 – 2033 (USD Million)
  • Chapter 6. Global Aesthetics Injectables Market – Application Analysis
    • 6.1 Global Aesthetics Injectables Market Overview: By Application
      • 6.1.1 Global Aesthetics Injectables Market Share, By Application, 2023 and 2033
    • 6.2 Facial Line Correction
      • 6.2.1 Global Aesthetics Injectables Market by Facial Line Correction, 2024 – 2033 (USD Million)
    • 6.3 Lip Augmentation
      • 6.3.1 Global Aesthetics Injectables Market by Lip Augmentation, 2024 – 2033 (USD Million)
    • 6.4 Facial Volume Restoration
      • 6.4.1 Global Aesthetics Injectables Market by Facial Volume Restoration, 2024 – 2033 (USD Million)
    • 6.5 Wrinkle Reduction
      • 6.5.1 Global Aesthetics Injectables Market by Wrinkle Reduction, 2024 – 2033 (USD Million)
    • 6.6 Others
      • 6.6.1 Global Aesthetics Injectables Market by Others, 2024 – 2033 (USD Million)
  • Chapter 7. Global Aesthetics Injectables Market – Gender Analysis
    • 7.1 Global Aesthetics Injectables Market Overview: By Gender
      • 7.1.1 Global Aesthetics Injectables Market Share, By Gender, 2023 and 2033
    • 7.2 Male
      • 7.2.1 Global Aesthetics Injectables Market by Male, 2024 – 2033 (USD Million)
    • 7.3 Female
      • 7.3.1 Global Aesthetics Injectables Market by Female, 2024 – 2033 (USD Million)
  • Chapter 8. Global Aesthetics Injectables Market – End-User Analysis
    • 8.1 Global Aesthetics Injectables Market Overview: By End-User
      • 8.1.1 Global Aesthetics Injectables Market Share, By End-User, 2023 and 2033
    • 8.2 Hospitals
      • 8.2.1 Global Aesthetics Injectables Market by Hospitals, 2024 – 2033 (USD Million)
    • 8.3 Dermatology Clinics
      • 8.3.1 Global Aesthetics Injectables Market by Dermatology Clinics, 2024 – 2033 (USD Million)
    • 8.4 Cosmetic Centers
      • 8.4.1 Global Aesthetics Injectables Market by Cosmetic Centers, 2024 – 2033 (USD Million)
    • 8.5 Ambulatory Surgical Centers
      • 8.5.1 Global Aesthetics Injectables Market by Ambulatory Surgical Centers, 2024 – 2033 (USD Million)
    • 8.6 Others
      • 8.6.1 Global Aesthetics Injectables Market by Others, 2024 – 2033 (USD Million)
  • Chapter 9. Aesthetics Injectable’s Market – Regional Analysis
    • 9.1 Global Aesthetics Injectable’s Market Regional Overview
    • 9.2 Global Aesthetics Injectable’s Market Share, by Region, 2023 & 2033 (USD Million)
    • 9.3. North America
      • 9.3.1 North America Aesthetics Injectable’s Market, 2024 – 2033 (USD Million)
        • 9.3.1.1 North America Aesthetics Injectable’s Market, by Country, 2024 – 2033 (USD Million)
    • 9.4 North America Aesthetics Injectable’s Market, by Product Type, 2024 – 2033
      • 9.4.1 North America Aesthetics Injectable’s Market, by Product Type, 2024 – 2033 (USD Million)
    • 9.5 North America Aesthetics Injectable’s Market, by Application, 2024 – 2033
      • 9.5.1 North America Aesthetics Injectable’s Market, by Application, 2024 – 2033 (USD Million)
    • 9.6 North America Aesthetics Injectable’s Market, by Gender, 2024 – 2033
      • 9.6.1 North America Aesthetics Injectable’s Market, by Gender, 2024 – 2033 (USD Million)
    • 9.7 North America Aesthetics Injectable’s Market, by End-User, 2024 – 2033
      • 9.7.1 North America Aesthetics Injectable’s Market, by End-User, 2024 – 2033 (USD Million)
    • 9.8. Europe
      • 9.8.1 Europe Aesthetics Injectable’s Market, 2024 – 2033 (USD Million)
        • 9.8.1.1 Europe Aesthetics Injectable’s Market, by Country, 2024 – 2033 (USD Million)
    • 9.9 Europe Aesthetics Injectable’s Market, by Product Type, 2024 – 2033
      • 9.9.1 Europe Aesthetics Injectable’s Market, by Product Type, 2024 – 2033 (USD Million)
    • 9.10 Europe Aesthetics Injectable’s Market, by Application, 2024 – 2033
      • 9.10.1 Europe Aesthetics Injectable’s Market, by Application, 2024 – 2033 (USD Million)
    • 9.11 Europe Aesthetics Injectable’s Market, by Gender, 2024 – 2033
      • 9.11.1 Europe Aesthetics Injectable’s Market, by Gender, 2024 – 2033 (USD Million)
    • 9.12 Europe Aesthetics Injectable’s Market, by End-User, 2024 – 2033
      • 9.12.1 Europe Aesthetics Injectable’s Market, by End-User, 2024 – 2033 (USD Million)
    • 9.13. Asia Pacific
      • 9.13.1 Asia Pacific Aesthetics Injectable’s Market, 2024 – 2033 (USD Million)
        • 9.13.1.1 Asia Pacific Aesthetics Injectable’s Market, by Country, 2024 – 2033 (USD Million)
    • 9.14 Asia Pacific Aesthetics Injectable’s Market, by Product Type, 2024 – 2033
      • 9.14.1 Asia Pacific Aesthetics Injectable’s Market, by Product Type, 2024 – 2033 (USD Million)
    • 9.15 Asia Pacific Aesthetics Injectable’s Market, by Application, 2024 – 2033
      • 9.15.1 Asia Pacific Aesthetics Injectable’s Market, by Application, 2024 – 2033 (USD Million)
    • 9.16 Asia Pacific Aesthetics Injectable’s Market, by Gender, 2024 – 2033
      • 9.16.1 Asia Pacific Aesthetics Injectable’s Market, by Gender, 2024 – 2033 (USD Million)
    • 9.17 Asia Pacific Aesthetics Injectable’s Market, by End-User, 2024 – 2033
      • 9.17.1 Asia Pacific Aesthetics Injectable’s Market, by End-User, 2024 – 2033 (USD Million)
    • 9.18. Latin America
      • 9.18.1 Latin America Aesthetics Injectable’s Market, 2024 – 2033 (USD Million)
        • 9.18.1.1 Latin America Aesthetics Injectable’s Market, by Country, 2024 – 2033 (USD Million)
    • 9.19 Latin America Aesthetics Injectable’s Market, by Product Type, 2024 – 2033
      • 9.19.1 Latin America Aesthetics Injectable’s Market, by Product Type, 2024 – 2033 (USD Million)
    • 9.20 Latin America Aesthetics Injectable’s Market, by Application, 2024 – 2033
      • 9.20.1 Latin America Aesthetics Injectable’s Market, by Application, 2024 – 2033 (USD Million)
    • 9.21 Latin America Aesthetics Injectable’s Market, by Gender, 2024 – 2033
      • 9.21.1 Latin America Aesthetics Injectable’s Market, by Gender, 2024 – 2033 (USD Million)
    • 9.22 Latin America Aesthetics Injectable’s Market, by End-User, 2024 – 2033
      • 9.22.1 Latin America Aesthetics Injectable’s Market, by End-User, 2024 – 2033 (USD Million)
    • 9.23. The Middle-East and Africa
      • 9.23.1 The Middle-East and Africa Aesthetics Injectable’s Market, 2024 – 2033 (USD Million)
        • 9.23.1.1 The Middle-East and Africa Aesthetics Injectable’s Market, by Country, 2024 – 2033 (USD Million)
    • 9.24 The Middle-East and Africa Aesthetics Injectable’s Market, by Product Type, 2024 – 2033
      • 9.24.1 The Middle-East and Africa Aesthetics Injectable’s Market, by Product Type, 2024 – 2033 (USD Million)
    • 9.25 The Middle-East and Africa Aesthetics Injectable’s Market, by Application, 2024 – 2033
      • 9.25.1 The Middle-East and Africa Aesthetics Injectable’s Market, by Application, 2024 – 2033 (USD Million)
    • 9.26 The Middle-East and Africa Aesthetics Injectable’s Market, by Gender, 2024 – 2033
      • 9.26.1 The Middle-East and Africa Aesthetics Injectable’s Market, by Gender, 2024 – 2033 (USD Million)
    • 9.27 The Middle-East and Africa Aesthetics Injectable’s Market, by End-User, 2024 – 2033
      • 9.27.1 The Middle-East and Africa Aesthetics Injectable’s Market, by End-User, 2024 – 2033 (USD Million)
  • Chapter 10. Company Profiles
    • 10.1 Allergan plc (now part of AbbVie)
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Galderma S.A.
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 Merz Pharma GmbH & Co. KGaA
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Sinclair Pharma plc
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 Suneva Medical Inc.
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Teoxane Laboratories
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 Anika Therapeutics Inc.
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 Prollenium Medical Technologies Inc.
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 Luminera Derm Ltd.
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments
    • 10.10 Revance Therapeutics Inc.
      • 10.10.1 Overview
      • 10.10.2 Financials
      • 10.10.3 Product Portfolio
      • 10.10.4 Business Strategy
      • 10.10.5 Recent Developments
    • 10.11 Ipsen Pharma
      • 10.11.1 Overview
      • 10.11.2 Financials
      • 10.11.3 Product Portfolio
      • 10.11.4 Business Strategy
      • 10.11.5 Recent Developments
    • 10.12 Laboratoires Vivacy SAS
      • 10.12.1 Overview
      • 10.12.2 Financials
      • 10.12.3 Product Portfolio
      • 10.12.4 Business Strategy
      • 10.12.5 Recent Developments
    • 10.13 SciVision Biotech Inc.
      • 10.13.1 Overview
      • 10.13.2 Financials
      • 10.13.3 Product Portfolio
      • 10.13.4 Business Strategy
      • 10.13.5 Recent Developments
    • 10.14 Merz Aesthetics Inc.
      • 10.14.1 Overview
      • 10.14.2 Financials
      • 10.14.3 Product Portfolio
      • 10.14.4 Business Strategy
      • 10.14.5 Recent Developments
    • 10.15 AQTIS Medical BV
      • 10.15.1 Overview
      • 10.15.2 Financials
      • 10.15.3 Product Portfolio
      • 10.15.4 Business Strategy
      • 10.15.5 Recent Developments
    • 10.16 Others.
      • 10.16.1 Overview
      • 10.16.2 Financials
      • 10.16.3 Product Portfolio
      • 10.16.4 Business Strategy
      • 10.16.5 Recent Developments
List Of Figures

Figures No 1 to 34

List Of Tables

Tables No 1 to 102

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2033

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2033
  • Market revenue estimates and forecasts up to 2033, by technology
  • Market revenue estimates and forecasts up to 2033, by application
  • Market revenue estimates and forecasts up to 2033, by type
  • Market revenue estimates and forecasts up to 2033, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Prominent Player

  • Allergan plc (now part of AbbVie)
  • Galderma S.A.
  • Merz Pharma GmbH & Co. KGaA
  • Sinclair Pharma plc
  • Suneva Medical Inc.
  • Teoxane Laboratories
  • Anika Therapeutics Inc.
  • Prollenium Medical Technologies Inc.
  • Luminera Derm Ltd.
  • Revance Therapeutics Inc.
  • Ipsen Pharma
  • Laboratoires Vivacy SAS
  • SciVision Biotech Inc.
  • Merz Aesthetics Inc.
  • AQTIS Medical BV
  • Others

FAQs

The key factors driving the Market are Aging Population, Increasing Beauty Consciousness, Technological Advancements, Rising Disposable Income, Expansion of Product Portfolio, Geographical Expansion.

The “Facial Line Correction” had the largest share in the global market for Aesthetics Injectables.

The “Botulinum Toxin” category dominated the market in 2023.

The key players in the market are Allergan plc (now part of AbbVie), Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma plc, Suneva Medical Inc., Teoxane Laboratories, Anika Therapeutics Inc., Prollenium Medical Technologies Inc., Luminera Derm Ltd., Revance Therapeutics Inc., Ipsen Pharma, Laboratoires Vivacy SAS, SciVision Biotech Inc., Merz Aesthetics Inc., AQTIS Medical BV, Others.

“North America” had the largest share in the Aesthetics Injectables Market.

The global market is projected to grow at a CAGR of 9.8% during the forecast period, 2024-2033.

The Aesthetics Injectables Market size was valued at USD 15,509.4 Million in 2024.

PURCHASE OPTIONS

$

3990


$

4990


$

5990


$

2290


$

2390

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • Report in your Language.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Report in your Language.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • In-Depth Company Profiles.
  • SWOT Analysis.
  • Identify your Competitors.
  • Recent Development Analysis.
  • Competitor Pricing Strategies.
  • Competitor Marketing Strategies.
  • Competitor Positioning and Messaging.
  • Competitor Product’s Strengths.
  • Free 20% or 10 Hours of Customisation.
  • 15% Discount on your Next Purchase.
  • Upgradable to other licenses.
  • PDF Format.
  • Permission to Print the Report.

Want to customize this report?
100% FREE CUSTOMIZATION!